Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients

International Urology and Nephrology

Volumn 40, Issue 1, 2008, Pages 233-239

  Onuigbo, Macaulay A C ^a,b   Onuigbo, Nnonyelum T C ^c  

^a Mayo Clinic College of Medicine   (United States)

^b Mayo Health System   (United States)

^c NT Systems   (United States)

Author keywords

ACE inhibitors; Angiotensin receptor blockers; Chronic kidney disease (CKD); ESRD; Microvascular renal artery stenosis (mRAS); RAAS blockade; Renal artery stenosis (RAS)

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CREATININE; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; LISINOPRIL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANALGESIC AGENT ABUSE; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DETERIORATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYPOVOLEMIA; IATROGENIC DISEASE; INFECTION; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FAILURE; MALE; MALIGNANT NEOPLASTIC DISEASE; MICROALBUMINURIA; OBSTRUCTIVE UROPATHY; ONSET AGE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SEPSIS; SEX RATIO; UNITED STATES; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AZOTEMIA; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; TIME FACTORS;

EID: 41549134762     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-007-9299-2     Document Type: Article

References (25)

1. Onuigbo M, Weir MR (2003) Evidence-based treatment of hypertension in patients with diabetes mellitus. Diabetes Obes Metab 5(1):13-26
2. Lewis EJ, Hunsicker LG, Bain RP et al (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329(20):1456-1462. (Erratum in: N Engl J Med 330(2):152
3. Ruggenenti P, Perna A, Gherardi G et al (1999) Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354(9176):359-364
4. Brenner BM, Cooper ME, de Zeeuw D et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869
5. Lewis EJ, Hunsicker LG, Clarke WR et al (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860
6. Nelson CR, Knapp DA (2000) Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians. Hypertension 36(4):600-603
7. Jones CA, Krolewski AS, Rogus J et al (2005) Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? Kidney Int 67(5):1684-1691
8. Centers for Disease Control, Prevention (CDC) (2007) Prevalence of chronic kidney disease and associated risk factors - United States, 1999-2004. MMWR Morb Mortal Wkly Rep 56(8):161-165
9. Pfeffer MA, Swedberg K, Granger CB et al (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-overall programme. Lancet 362(9386):759-766
10. Suissa S, Hutchinson T, Brophy JM et al (2006) ACE-inhibitor use and the long-term risk of renal failure in diabetes. Kidney Int 69:913-919
11. Kalra PA, Mamtora H, Holmes AM et al (1990) Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy. Q J Med 77(282):1013-1018
12. Devoy MAB, Tomson CR, Edmunds ME et al (1992) Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J Intern Med 232(6):493-498
13. Thomas MC (2000) Diuretics, ACE inhibitors and NSAIDs - the triple whammy. Med J Aust 172(4):184-185
14. Descombes E, Fellay G (2000) End-stage renal failure after irbesartan prescription in a diabetic patient with previously stable chronic renal insufficiency. Ren Fail 22(6):815-821
15. Vachharajani TJ, Dacie JE, Yaqoob MM et al (2005) Detection of occult renovascular disease in unexplained chronic kidney disease. Int Urol Nephrol 37(4):793-796
16. Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130(6):461-470
17. Onuigbo M, Onuigbo N (2007) Renal failure from RAAS blockade in CKD patients: A prospective 50-month analysis - A call for pragmatic caution to optimize cardiorenal protection with RAAS blockade. Am J Kidney Dis 49(4):A64 (abstract #159)
18. Onuigbo MAC, Onuigbo NTC (2006) Late-onset renal failure from RAAS blockade. Kidney Int 70:1378-1379 (Letter to editor)
19. Hansen HP, Rossing P, Tarnow L et al (1995) Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 47(6):1726-1731
20. Apperloo AJ, de Zeeuw D, de Jong PE (1997) A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Ann Intern Med 51(3):793-797
21. Raine AE (1990) Angiotensin-converting enzyme inhibition and renovascular disease. Q J Med 77(282):997-999
22. Ballermann BJ, Onuigbo MAC (2000) Angiotensins. In: Handbook of Physiology, edited by Fray, JCS: Section 7, The Endocrine System, Vol III. Endocrine Regulation of water and electrolyte balance. New York, NY: Oxford University Press; pp 104-155
23. Tsalamandris C, Allen TJ, Gilbert RE et al (1994) Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 43(5):649-655
24. Onuigbo MA (2003) Causes of renal failure in patients with type 2 diabetes mellitus. JAMA 290(14):1855 (Letter to the Editor)
25. Bakris GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: Is this a cause for concern? Arch Intern Med 160(5):685-693